136 related articles for article (PubMed ID: 9290699)
21. Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma.
Satake N; Urakami S; Hirayama Y; Izumi K; Hino O
Int J Cancer; 1998 Sep; 77(6):895-900. PubMed ID: 9714060
[TBL] [Abstract][Full Text] [Related]
22. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H
Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
Cario H; Schwarz K; Jorch N; Kyank U; Petrides PE; Schneider DT; Uhle R; Debatin KM; Kohne E
Haematologica; 2005 Jan; 90(1):19-24. PubMed ID: 15642664
[TBL] [Abstract][Full Text] [Related]
24. A novel germline mutation in the von Hippel-Lindau gene in patients in Kuwait.
Alfadhli S; Salim M; Al-Awadi S
Med Princ Pract; 2004; 13(6):312-5. PubMed ID: 15467305
[TBL] [Abstract][Full Text] [Related]
25. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
26. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas.
Kikuchi Y; Kobayashi E; Nishizawa M; Hamazaki S; Okada S; Hino O
Jpn J Cancer Res; 1995 Oct; 86(10):905-9. PubMed ID: 7493907
[TBL] [Abstract][Full Text] [Related]
27. Germline mutation in the von Hippel-Lindau gene in Kuwait: a clinical and molecular study.
AlFadhli SM; Mohammed B; Yassin A
Med Princ Pract; 2008; 17(5):395-9. PubMed ID: 18685280
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H
Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214
[TBL] [Abstract][Full Text] [Related]
29. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
30. EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors.
Franco-Hernandez C; Martinez-Glez V; Arjona D; de Campos JM; Isla A; Gutierrez M; Vaquero J; Rey JA
Cancer Genet Cytogenet; 2007 Feb; 173(1):63-7. PubMed ID: 17284372
[TBL] [Abstract][Full Text] [Related]
31. Human CFTR gene sequences in regions flanking exon 10: a simple repeat sequence polymorphism in intron 9.
Xu Z; Gruenert DC
Biochem Biophys Res Commun; 1996 Feb; 219(1):140-5. PubMed ID: 8619797
[TBL] [Abstract][Full Text] [Related]
32. Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds.
Ohgaki H; Hard GC; Hirota N; Maekawa A; Takahashi M; Kleihues P
Cancer Res; 1992 May; 52(10):2995-8. PubMed ID: 1316233
[TBL] [Abstract][Full Text] [Related]
33. Activation of the K-ras gene by insertion mutations in chemically induced rat renal mesenchymal tumors.
Higinbotham KG; Rice JM; Buzard GS; Perantoni AO
Oncogene; 1994 Sep; 9(9):2455-9. PubMed ID: 8058308
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma.
Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL
Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813
[TBL] [Abstract][Full Text] [Related]
35. Novel p53 mutation in a malignant tumor secreting vasoactive intestinal peptide.
Lin HJ; French SW; Reichenbach D; Wan YJ; Passaro E; Sawicki MP
Arch Pathol Lab Med; 1997 Feb; 121(2):125-8. PubMed ID: 9126038
[TBL] [Abstract][Full Text] [Related]
36. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.
Zhuang Z; Bertheau P; Emmert-Buck MR; Liotta LA; Gnarra J; Linehan WM; Lubensky IA
Am J Pathol; 1995 Mar; 146(3):620-5. PubMed ID: 7887444
[TBL] [Abstract][Full Text] [Related]
37. TP53 intronic mutations in bovine enzootic hematuria-associated urinary bladder tumors.
Sasani F; Baghban F; Nikbakht Brujeni GH; Kazemi M
Vet Pathol; 2013 May; 50(3):543-7. PubMed ID: 23242803
[TBL] [Abstract][Full Text] [Related]
38. Nephroblastoma and renal mesenchymal tumor induced in rats by N-nitrosoethyl- and N-nitrosomethylurea.
Turusov VS; Alexandrov VA; Timoshenko IV
Neoplasma; 1980; 27(3):229-35. PubMed ID: 6256671
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancers.
Bailly M; Bain C; Favrot MC; Ozturk M
Int J Cancer; 1995 Nov; 63(5):660-4. PubMed ID: 7591282
[TBL] [Abstract][Full Text] [Related]
40. A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea.
Sharma PM; Bowman M; Yu BF; Sukumar S
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9931-5. PubMed ID: 7937920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
